A detailed history of Ubs Group Ag transactions in In Med Pharmaceuticals Inc. stock. As of the latest transaction made, Ubs Group Ag holds 212,039 shares of INM stock, worth $945,693. This represents 0.0% of its overall portfolio holdings.

Number of Shares
212,039
Holding current value
$945,693
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.12 - $0.43 $25,444 - $91,176
212,039 New
212,039 $50,000
Q1 2024

May 13, 2024

BUY
$0.32 - $0.44 $13 - $18
41 New
41 $0
Q3 2023

Nov 09, 2023

BUY
$0.69 - $1.22 $47 - $84
69 New
69 $0
Q1 2023

May 12, 2023

BUY
$1.05 - $2.3 $1,880 - $4,119
1,791 Added 215.52%
2,622 $2,000
Q4 2022

Feb 08, 2023

SELL
$1.32 - $7.95 $6,555 - $39,479
-4,966 Reduced 85.66%
831 $1,000
Q3 2022

Nov 10, 2022

BUY
$5.11 - $18.78 $29,622 - $108,867
5,797 New
5,797 $38,000

Others Institutions Holding INM

About InMed Pharmaceuticals Inc.


  • Ticker INM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 908,761
  • Market Cap $4.05M
  • Description
  • InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in precl...
More about INM
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.